Effects of renal impairment on the pharmacokinetics of orally administered deferiprone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of renal impairment on the pharmacokinetics of orally administered deferiprone

Published:2016-07-18 Issue:4 Volume:82 Page:994-1001
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Fradette Caroline¹,Pichette Vincent²,Sicard Éric³,Stilman Anne¹,Jayashankar Shalini¹,Tsang Yu Chung¹,Spino Michael¹⁴,Tricta Fernando¹

Affiliation:

1. ApoPharma Inc. 200 Barmac Drive Toronto Ontario M9L 2Z7 Canada

2. Hôpital Maisonneuve‐Rosemont 5415 Assomption Boulevard Montreal Quebec H1T 2M4 Canada

3. Algorithme Pharma 575 Armand-Frappier Blvd. Laval Quebec H7V 4B3 Canada

4. Leslie Dan Faculty of Pharmacy 144 College St Toronto Ontario M5S 3M2 Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13037

Reference31 articles.

1. Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to β-Thalassemia

3. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

4. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

5. Renal aspects of thalassaemia a changing paradigm

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group;Acta Haematologica;2023-12-16

2. Interpreting Iron Homeostasis in Congenital and Acquired Disorders;Pharmaceuticals;2023-02-21

3. An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes;Expert Review of Hematology;2023-02-01

4. The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease;Annals of Hematology;2022-01-04

5. Metabolic activation of deferiprone mediated by CYP2A6;Xenobiotica;2021-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3